Atai Beckley N.V - Common Shares (NQ:ATAI)

4.320 -0.080 (-1.82%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Price and Volume

Volume	2,849,306
Open	4.410
Bid (Size)	4.250 (100)
Ask (Size)	4.350 (20,700)
Prev. Close	4.400
Today's Range	4.220 - 4.455
52wk Range	1.150 - 6.750
Shares Outstanding	166,010,476
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London

November 13, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 12, 2025

AtaiBeckley solidifies position as a global leader in transformative mental health therapies with a short psychedelic duration

From AtaiBeckley N.V.

Via GlobeNewswire

Performance

YTD	+170.0%	+170.0%
1 Month	-3.6%	-3.6%
3 Month	-5.5%	-5.5%
6 Month	+79.3%	+79.3%
1 Year	+189.9%	+189.9%

More News

AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression

November 10, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies

November 05, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

Analyst Expectations For ATAI Life Sciences's Future ↗

October 22, 2025

Via Benzinga

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

October 20, 2025

From atai Life Sciences

Via GlobeNewswire

Why Atai Life Sciences Stock Was So Lively This Week ↗

October 17, 2025

Via The Motley Fool

atai Life Sciences Announces Pricing of Public Offering of Common Shares

October 16, 2025

From atai Life Sciences

Via GlobeNewswire

atai Life Sciences Announces Proposed Public Offering of Common Shares

October 16, 2025

From atai Life Sciences

Via GlobeNewswire

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

October 16, 2025

From atai Life Sciences

Via GlobeNewswire

Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides

October 14, 2025

Via MarketMinute

Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside ↗

October 13, 2025

Via Benzinga

Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

September 24, 2025

Via Benzinga

Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews ↗

September 23, 2025

Via Benzinga

Why Atai Life Sciences Stock Crushed It on Tuesday ↗

September 23, 2025

Via The Motley Fool

Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients ↗

September 23, 2025

Via Benzinga

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

September 23, 2025

From atai Life Sciences

Via GlobeNewswire

MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI

September 19, 2025

Via Investor Brand Network

Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225% ↗

September 18, 2025

Via Benzinga

atai Life Sciences Awarded Grant from the National Institutes of Health

September 18, 2025

From atai Life Sciences

Via GlobeNewswire

atai Life Sciences to Participate in September Investor Conferences

August 28, 2025

From atai Life Sciences

Via GlobeNewswire

Atai Life Sciences Revenue Jumps 163% ↗

August 14, 2025

Via The Motley Fool

atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

August 14, 2025

From atai Life Sciences

Via GlobeNewswire

This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

July 30, 2025

Via Benzinga

This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday ↗

July 29, 2025

Via Benzinga

Frequently Asked Questions

Is Atai Beckley N.V - Common Shares publicly traded?

Yes, Atai Beckley N.V - Common Shares is publicly traded.

What exchange does Atai Beckley N.V - Common Shares trade on?

Atai Beckley N.V - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Atai Beckley N.V - Common Shares?

The ticker symbol for Atai Beckley N.V - Common Shares is ATAI on the Nasdaq Stock Market

What is the current price of Atai Beckley N.V - Common Shares?

The current price of Atai Beckley N.V - Common Shares is 4.320

When was Atai Beckley N.V - Common Shares last traded?

The last trade of Atai Beckley N.V - Common Shares was at 12/05/25 04:00 PM ET

What is the market capitalization of Atai Beckley N.V - Common Shares?

The market capitalization of Atai Beckley N.V - Common Shares is 717.17M

How many shares of Atai Beckley N.V - Common Shares are outstanding?

Atai Beckley N.V - Common Shares has 717M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.